Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 23679916)

1.

Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.

Wu J, Song C, Jiang C, Shen X, Qiao Q, Hu Y.

Mol Pharm. 2013 Oct 7;10(10):3555-63. doi: 10.1021/mp300686g. Epub 2013 Aug 28.

PMID:
23679916
2.

Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Ding D, Tang X, Cao X, Wu J, Yuan A, Qiao Q, Pan J, Hu Y.

AAPS PharmSciTech. 2014 Feb;15(1):213-22. doi: 10.1208/s12249-013-0041-3. Epub 2013 Nov 28.

3.

The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.

Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ.

Cancer Res. 2008 Apr 1;68(7):2358-65. doi: 10.1158/0008-5472.CAN-07-5723.

4.

Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.

Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D, Spicer EK, Fernandes DJ.

Mol Pharmacol. 2009 Nov;76(5):984-91. doi: 10.1124/mol.109.055947. Epub 2009 Aug 5.

5.

Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.

Zhou W, Zhou Y, Wu J, Liu Z, Zhao H, Liu J, Ding J.

J Drug Target. 2014 Jan;22(1):57-66. doi: 10.3109/1061186X.2013.839683. Epub 2013 Oct 24.

PMID:
24156476
6.

Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.

Yu C, Hu Y, Duan J, Yuan W, Wang C, Xu H, Yang XD.

PLoS One. 2011;6(9):e24077. doi: 10.1371/journal.pone.0024077. Epub 2011 Sep 1.

7.

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

Aravind A, Jeyamohan P, Nair R, Veeranarayanan S, Nagaoka Y, Yoshida Y, Maekawa T, Kumar DS.

Biotechnol Bioeng. 2012 Nov;109(11):2920-31. doi: 10.1002/bit.24558. Epub 2012 Jun 1.

PMID:
22615073
8.

A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

Reyes-Reyes EM, Teng Y, Bates PJ.

Cancer Res. 2010 Nov 1;70(21):8617-29. doi: 10.1158/0008-5472.CAN-10-0920. Epub 2010 Sep 21.

9.

A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.

Hwang do W, Ko HY, Lee JH, Kang H, Ryu SH, Song IC, Lee DS, Kim S.

J Nucl Med. 2010 Jan;51(1):98-105. doi: 10.2967/jnumed.109.069880. Epub 2009 Dec 15.

10.

Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.

Feng Q, Yu MZ, Wang JC, Hou WJ, Gao LY, Ma XF, Pei XW, Niu YJ, Liu XY, Qiu C, Pang WH, Du LL, Zhang Q.

Biomaterials. 2014 Jun;35(18):5028-38. doi: 10.1016/j.biomaterials.2014.03.012. Epub 2014 Mar 27.

PMID:
24680191
11.

Nucleolin on the cell surface as a new molecular target for gastric cancer treatment.

Watanabe T, Hirano K, Takahashi A, Yamaguchi K, Beppu M, Fujiki H, Suganuma M.

Biol Pharm Bull. 2010;33(5):796-803.

12.

Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.

Ma Q, Li B, Yu Y, Zhang Y, Wu Y, Ren W, Zheng Y, He J, Xie Y, Song X, He G.

Int J Pharm. 2013 Mar 10;445(1-2):88-92. doi: 10.1016/j.ijpharm.2013.01.046. Epub 2013 Jan 31.

PMID:
23376505
13.

Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.

Yu B, Tang C, Yin C.

Biomaterials. 2014 Aug;35(24):6369-78. doi: 10.1016/j.biomaterials.2014.04.095. Epub 2014 May 10.

PMID:
24818887
14.

The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.

Fu Y, Chen Y, Luo X, Liang Y, Shi H, Gao L, Zhan S, Zhou D, Luo Y.

Biochemistry. 2009 Dec 15;48(49):11655-63. doi: 10.1021/bi901265z.

PMID:
19877579
15.

Selective collection and detection of MCF-7 breast cancer cells using aptamer-functionalized magnetic beads and quantum dots based nano-bio-probes.

Hua X, Zhou Z, Yuan L, Liu S.

Anal Chim Acta. 2013 Jul 25;788:135-40. doi: 10.1016/j.aca.2013.06.001. Epub 2013 Jun 20.

PMID:
23845492
16.

Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H.

Biomaterials. 2011 Nov;32(31):8010-20. doi: 10.1016/j.biomaterials.2011.07.004. Epub 2011 Jul 23.

PMID:
21788069
18.

Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.

Xing H, Tang L, Yang X, Hwang K, Wang W, Yin Q, Wong NY, Dobrucki LW, Yasui N, Katzenellenbogen JA, Helferich WG, Cheng J, Lu Y.

J Mater Chem B Mater Biol Med. 2013 Oct 21;1(39):5288-5297.

19.

Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.

Song N, Liu W, Tu Q, Liu R, Zhang Y, Wang J.

Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):454-63. doi: 10.1016/j.colsurfb.2011.06.009. Epub 2011 Jun 15.

PMID:
21719259
20.

Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.

Zhao T, Chen H, Dong Y, Zhang J, Huang H, Zhu J, Zhang W.

Int J Nanomedicine. 2013;8:1947-57. doi: 10.2147/IJN.S44220. Epub 2013 May 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk